Tardiff Jil C
Albert Einstein College of Medicine, Yeshiva University, Bronx, New York 10461, USA.
J Clin Invest. 2006 Jun;116(6):1467-70. doi: 10.1172/JCI28884.
The question of what differentiates physiological from pathological cardiac hypertrophy remains one of the most clinically relevant questions in basic cardiovascular research. The answer(s) to this question will have far-ranging importance in the fight against hypertrophic heart disease and failure. In this issue of the JCI, Perrino et al. have used a unique model system to mimic the pathophysiologic effects of an intermittent pressure overload on the heart--in effect, to examine the basic issue of what determines an in vivo pathogenic stimulus (see the related article beginning on page 1547). Their findings clearly show that it is the nature of the inciting stimulus, as opposed to chronicity, that establishes the initial pathogenic response and that a distinct disruption of the beta-adrenergic system is centrally involved in the earliest alterations of myocellular physiology. These results suggest both a new paradigm for treatment options in hypertrophic cardiac disease and novel methodologies for further studies.
区分生理性心脏肥大与病理性心脏肥大的问题仍然是基础心血管研究中最具临床相关性的问题之一。该问题的答案对于对抗肥厚性心脏病和心力衰竭具有广泛的重要性。在本期《临床研究杂志》中,佩里诺等人使用了一种独特的模型系统来模拟间歇性压力超负荷对心脏的病理生理影响——实际上,是为了研究决定体内致病刺激的基本问题(见第1547页开始的相关文章)。他们的研究结果清楚地表明,引发刺激的性质而非慢性程度决定了最初的致病反应,并且β-肾上腺素能系统的明显破坏在心肌细胞生理学的最早改变中起核心作用。这些结果为肥厚性心脏病的治疗选择提出了新的范例,并为进一步研究提供了新的方法。